atorvastatin has been researched along with Chronic Lung Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, DW; Shih, HC; Wang, CY | 1 |
| Du, J; Meng, X; Wang, J; Wang, R; Xie, H; Zhou, Z; Zhu, Y | 1 |
| Gitirana, LB; Machado, MN; Magalhães, CB; Melo, AC; Porto, LC; Ribeiro, ML; Santos, JC; Valença, SS; Zin, WA | 1 |
3 other study(ies) available for atorvastatin and Chronic Lung Injury
| Article | Year |
|---|---|
N-acetylcysteine and atorvastatin alleviates lung injury due to ischemia-reperfusion injury in rats.
Topics: Acetylcysteine; Animals; Atorvastatin; Cytokines; Lung Injury; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2019 |
Atorvastatin attenuates paraquat poisoning-induced epithelial-mesenchymal transition via downregulating hypoxia-inducible factor-1 alpha.
Topics: A549 Cells; Animals; Atorvastatin; Cadherins; Cell Line; Epithelial-Mesenchymal Transition; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Lung Injury; Male; Paraquat; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Signal Transduction; Zonula Occludens-1 Protein | 2018 |
Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury.
Topics: Animals; Atorvastatin; Biomarkers; Endotoxins; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lung Injury; Male; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Pravastatin; Pyrroles; Simvastatin | 2013 |